Utah researcher wins grant to study potentially deadly melanoma genes
Laura Seitz, Deseret News
SALT LAKE CITY — A Utah researcher is getting big money to study specific genes that play a role in the cause and spreading of melanoma.
Dr. Matt VanBrocklin, a Huntsman Cancer Institute investigator and assistant professor in the University of Utah's Department of Surgery, received $1.5 million from the National Cancer Institute to continue his research on mutations in c-KIT, already identified as the most common cancer-causing event in certain melanomas, including those caused by chronic sun damage.
VanBrocklin is using mice to track the role of c-KIT and test whether active c-KIT can cause melanoma, a devastating and sometimes deadly skin cancer.
"We need to discover more details about how c-KIT works in melanoma tumors and what other genetic factors may be interacting with it as the cancer progresses and spreads to other parts of the body," he said. The goal of the ongoing research is to develop new, more effective treatments for patients whose tumors have similar gene mutations.
More than 76,600 people have been diagnosed with melanoma in the United States this year, and the disease has killed more than 9,480 people so far, according to the National Institutes of Health, which presented the grant to VanBrocklin.
— Wendy Leonard
- Man stole ring, woman swallowed it, police say
- World-renowned rock art in Utah is younger...
- Wet, cool August delivered more than twice...
- Lessons from Napa: Earthquake warns Utahns of...
- Family of fallen officer Derek Johnson...
- Circleville farmers scratching their heads...
- No timeline announced yet for Cottonwood Mall...
- Becky Lockhart serious about superintendent...
- Attorney general deciding whether to... 41
- Running again? Mitt Romney tells Hugh... 39
- Newborn found in trash can brings call... 34
- Becky Lockhart serious about... 31
- Parents say daughter didn't understand... 22
- Gay rights activists to fight charges... 22
- Police reviewing possible nightclub... 16
- Winning plaintiffs in 3 states want... 14